Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Ishibashi et al.
J. Pharmacol. Exp. Ther. 2010;334:171-181.
ABSTRACT
| FULL TEXT
Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia
Liu et al.
J Psychopharmacol 2009;23:937-943.
ABSTRACT
Five-Year Follow-up of a Randomized Multicenter Trial of Intensive Early Intervention vs Standard Treatment for Patients With a First Episode of Psychotic Illness: The OPUS Trial
Bertelsen et al.
Arch Gen Psychiatry 2008;65:762-771.
ABSTRACT
| FULL TEXT
Sex Differences in the Cerebral Function Associated with Processing Of Aversive Stimuli by Schizophrenia Patients
Mendrek et al.
Aust N Z J Psychiatry 2007;41:136-141.
ABSTRACT
| FULL TEXT
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis: One-year follow-up of a randomised controlled trial
NORDENTOFT et al.
Br. J. Psychiatry 2002;181:s98-s106.
ABSTRACT
| FULL TEXT
Relationship Between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives
Fanous et al.
Arch Gen Psychiatry 2001;58:669-673.
ABSTRACT
| FULL TEXT
Rehabilitation Programmes and Quality of Life in Severe Mental Illness
Browne
Int J Soc Psychiatry 1999;45:302-309.
ABSTRACT
Gender and Schizophrenia: Association of Age at Onset with Antecedent, Clinical and Outcome Features
Gureje and Bamidele
Aust N Z J Psychiatry 1998;32:415-423.
ABSTRACT
Outcome of Schizophrenia: The Madras Longitudinal Study
Thara and Eaton
Aust N Z J Psychiatry 1996;30:516-522.
ABSTRACT
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen et al.
Arch Gen Psychiatry 1995;52:341-351.
ABSTRACT
Signs and Symptoms: What Can They Tell Us About the Clinical Course and Pathophysiologic Processes of Schizophrenia?
Lieberman
Arch Gen Psychiatry 1995;52:361-363.
ABSTRACT
Structure and Course of Positive and Negative Symptoms in Schizophrenia
Eaton et al.
Arch Gen Psychiatry 1995;52:127-134.
ABSTRACT
Treatment of Abulia with Carbidopa/Levodopa
Drubach et al.
Neurorehabil Neural Repair 1995;9:151-155.
ABSTRACT
The Influence of Illness Duration on Syndrome Clarity and Stability in Functional Psychosis: Does the Diagnosis Emerge and Stabilise with Time?
McGorry
Aust N Z J Psychiatry 1994;28:607-619.
ABSTRACT
Testing Systems for Assessment of Negative Symptoms in Schizophrenia
Fenton and McGlashan
Arch Gen Psychiatry 1992;49:179-184.
ABSTRACT
The Positive-Negative Distinction in Schizophrenia: Review of Natural History Validators
McGlashan and Fenton
Arch Gen Psychiatry 1992;49:63-72.
ABSTRACT
Natural History of Schizophrenia Subtypes: II. Positive and Negative Symptoms and Long-term Course
Fenton and McGlashan
Arch Gen Psychiatry 1991;48:978-986.
ABSTRACT
